您的购物车当前为空
别名 EGR240
ERG240 是支链氨基酸转氨酶 1 (BCAT1) 抑制剂。ERG240 有潜力用于癌症、类风湿性关节炎和骨病相关研究。


为众多的药物研发团队赋能,
让新药发现更简单!
ERG240 是支链氨基酸转氨酶 1 (BCAT1) 抑制剂。ERG240 有潜力用于癌症、类风湿性关节炎和骨病相关研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 240 | In Stock | |
| 5 mg | ¥ 530 | In Stock | |
| 10 mg | ¥ 768 | In Stock | |
| 25 mg | ¥ 1,270 | In Stock | |
| 50 mg | ¥ 1,890 | In Stock | |
| 100 mg | ¥ 2,790 | In Stock | |
| 200 mg | ¥ 4,170 | In Stock |
| 产品描述 | ERG240 is an inhibitor of branched-chain amino acid aminotransferase 1 (BCAT1). ERG240 can be used for the research of rheumatoid arthritis, cancer, and bone disease. |
| 别名 | EGR240 |
| 分子量 | 166.15 |
| 分子式 | C7H11NaO3 |
| CAS No. | 1415683-79-2 |
| Smiles | CC(C(C)CCC([O-])=O)=O.[Na+] |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 90 mg/mL (541.68 mM), Sonication is recommended. H2O: 90 mg/mL (541.68 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO/H2O
| ||||||||||||||||||||||||||||||||||||
评论内容